gen: 2026/08/09:13:26 in 49.0 sec (old)bias: 3 (Center-Left)
type: newsquality: 82
pts: 0
Generated
#healthcare#india#counterfeits#cancer#drugs#cancerdrugs#counterfeit#keytruda#merck#icij
Fake vials haunt sick wards  
New codes will trace cancer drugs  
Hope scans every dose
Holder
author:Nicole Sadekinstitution:International Consortium of Investigative Journalists (ICIJ)¿porque no los dos?
tl;drAn ICIJ report says India is tightening “track and trace” rules for cancer drugs after a counterfeit Keytruda scandal exposed how high prices and scarcity can be exploited. New requirements include mandatory QR codes and unit-level identifiers (e.g., unique code, manufacture/expiry dates, manufacturer details) for medicines sold in India, including some imports. The story cites Health Ministry statements, prior investigations with The Indian Express, and a 2024 case in New Delhi involving refilled vials and cross-border impacts (including Nepal).
deeper:The piece is largely factual and specific (dates, agencies, prior case details, and described regulatory changes). Its framing emphasizes patient harm, high pricing, and public-interest accountability—common in investigative health reporting—without heavy ideological rhetoric. It relies on official sources and earlier documented investigations, but offers limited space for countervailing views from manufacturers or enforcement challenges beyond brief mentions (e.g., “foolproof” concerns). Overall, it is clear, well-sourced, and informative.
media:
Enter the Arena

Please log in to comment